Senior Vice President, Research & Development, ModMab Therapeutics, Inc.
BIOGRAPHY
FEB 27, 2019 3:00 PM PST
Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates
Presented at:
Drug Discovery Virtual Event Series 2019
Speaker
Abstract
In today's presentation I will give an overview to developing NextGen ADCs. We will discuss everything from the beginning stages of development to the varying ADC combination therapies available. (There are currently 23 ADCs in total being studied in 45 combination trials with 10 different immune checkpoint modulators).
Learning Objectives:
1. This presentation will discuss past, present challenges associated with developing antibody-drug conjugates (ADCs), a novel modality of targeted cancer chemotherapy
2. Presentation will also highlight key factors that influence in developing next generation ADCs.
You May Also Like
FEB 15, 2023 | 7:00 AM
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
JUN 06, 2023 | 8:00 AM
C.E. CREDITS
As the life sciences industry continues to evolve, so does the need for advanced laboratory management solutions that can help improve efficiency, streamline workflows, and ensure compliance...
MAY 31, 2023 | 11:00 AM
Date: May 31, 2023 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CET) Single-cell genomics has facilitated the understanding of mechanisms involved in various biological processes such as tumor...
APR 11, 2023 | 8:00 AM
C.E. CREDITS
Date: April 11, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Duchenne muscular dystrophy is caused by mutations in the dystrophin encoding DMD gene that disrupt the reading frame. M...
DEC 07, 2022 | 8:00 AM
C.E. CREDITS
Date: December 7, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Join Tom Fletcher, Scientific Director, Research and Development, and Guy Matthews, Director of Single Use Technologie...
FEB 28, 2023 | 8:00 AM
C.E. CREDITS
Date: February 28, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Prenatal infections can increase the risk of serious health complications including miscarriage, organ damage, birth...
FEB 27, 2019 3:00 PM PST
Share
Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates
Presented at:
Drug Discovery Virtual Event Series 2019
Loading Comments...
Finish Registering
-
JUN 01, 2023Thomas Experts Series -
JUN 08, 20232023 Lab Compliance Connect
-
JUL 18, 2023Precision Medicine in Solid Tumors
-
SEP 05, 2023Microbiology Week Virtual Event Series 2023
-
SEP 12, 2023The Power of Plexing: 3rd Annual TMT Symposium
-
SEP 20, 2023Cell Biology Virtual Event Series 2023
- See More
-
JUN 05, 2023
-
JUN 05, 2023
-
JUN 05, 2023
- See More
-
Beckman Coulter Life SciencesBiomek NGeniuS Next Generation Library Prep System
-
Beckman Coulter Life SciencesEMnetik System: PCR Cleanup and Plasmid Prep
-
Beckman Coulter Life SciencesAMPure XP Reagent for PCR Purification
-
Beckman Coulter Life SciencesSPRIselect Reagent
-
Beckman Coulter Life SciencesRNAClean XP Reagent
-
Beckman Coulter Life SciencesApostle MiniMax™ High Efficiency Isolation Kit
- See More
